News
News Brief
April 2, 2020
As part of our work in criminal justice settings, our subject matter experts (SMEs) understand the risks of COVID-19 infection for the personnel and justice-involved individuals: those facing prosecution and pre-trial proceedings in the courthouses, placed on court-supervised probation, incarcerated in the nation’s jails and prisons, and released and on court-supervised parole. Regardless of the setting, of special concern are justice-involved individuals with chronic diseases, such as SUDs and mental disorders.
News Brief
March 26, 2020
This is a time of great uncertainty, and it is difficult to consider how quickly and radically our daily lives have been changed by the COVID-19 pandemic. Our thoughts go out to everyone impacted, and our gratitude goes out to the healthcare professionals and other essential workers putting themselves at risk for exposure to this virus and working tirelessly to assist others.
News Brief
March 25, 2020
As part of our ongoing support of those in need amidst the COVID-19 pandemic, JBS subject experts provided guidance for patients and providers of opioid agonist therapy who face unique challenges at this time. This JBS News Brief addresses the following topics and is part of our dedication to helping real people make real progress:
- Social Distancing in OTPs
- OTP Patients and Self-Quarantine
- Telehealth and Buprenorphine Maintenance in the Office-Based Setting
News Brief
March 20, 2020
For the past 35 years, JBS has worked with national, state, and local systems to address substance use disorders and mental health and their impact on society. In keeping with our dedication to helping real people make real progress, JBS subject experts provide guidance amidst the COVID-19 pandemic on meeting the need for critical treatment services and social connection during a period of recommended social isolation.
News Brief
September 26, 2019
North Bethesda, MD – JBS International is among the Phase II winners of the Grand Challenges sponsored by the U.S. Health Resources and Services Administration (HRSA)’s Maternal and Child Health Bureau (MCHB) to spark innovative technological solutions to critical maternal and child health issues. JBS is developing a mobile application that uses Artificial Intelligence (AI) to put clinical guidelines at the fingertips of health care professionals treating pregnant women and new moms experiencing opioid use disorder (OUD).